Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024-05 · 1879 (3) · 189099
DOI: 10.1016/j.bbcan.2024.189099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024-05. Verfasst von Hongli Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Neoplasms, Signal Transduction, Ubiquitination. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Protein ubiquitination, one of the most significant post-translational modifications, plays an important role in controlling the proteins activity in diverse cellular processes. The reversible process of protein ubiquitination, known as deubiquitination, has emerged as a critical mechanism for maintaining cellular homeostasis. The deubiquitinases (DUBs), which participate in deubiquitination process are increasingly recognized as potential candidates for drug discovery. Among these DUBs, ubiquitin-specific protease 9× (USP9X), a highly conserved member of the USP family, exhibits versatile functions in various cellular processes, including the regulation of cell cycle, protein endocytosis, apoptosis, cell polarity, immunological microenvironment, and stem cell characteristics. The dysregulation and abnormal activities of USP9X are influenced by intricate cellular signaling pathway crosstalk and upstream non-coding RNAs. The complex expression patterns and controversial clinical significance of USP9X in cancers suggest its potential as a prognostic biomarker. Furthermore, USP9X inhibitors has shown promising antitumor activity and holds the potential to overcome therapeutic resistance in preclinical models. However, a comprehensive summary of the role and molecular functions of USP9X in cancer progression is currently lacking. In this review, we provide a comprehensive delineation of USP9X participation in numerous critical cellular processes, complicated signaling pathways within the tumor microenvironment, and its potential translational applications to combat therapeutic resistance. By systematically summarizing the updated molecular mechanisms of USP9X in cancer biology, this review aims to contribute to the advancement of cancer therapeutics and provide essential insights for specialists and clinicians in the development of improved cancer treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China.
- Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: cji@cmu.edu.cn.
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China. Electronic address: xingfshengjing@sina.com.
Zitieren
APA
Gao, H., Chen, Z., Zhao, L., Ji, C., & Xing, F. (2024). Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1879(3), 189099. https://doi.org/10.1016/j.bbcan.2024.189099
Vancouver
Gao H, Chen Z, Zhao L, Ji C, Xing F. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024;1879(3):189099. doi:10.1016/j.bbcan.2024.189099
BibTeX
@article{Gao2024,
author = {Gao, Hongli and Chen, Zhiguang and Zhao, Liang and Ji, Ce and Xing, Fei},
title = {Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2024},
volume = {1879},
number = {3},
pages = {189099},
doi = {10.1016/j.bbcan.2024.189099}
}
EUVIMED